Skip to content
value.today

Leafline Labs, LLC

🇺🇸 Minneapolis, Minnesota, USAPharmaceuticalsFounded 2014
Total raised
$15 M
1 round on record
Latest round
$15 M
Dec 2014
First round on record
Dec 2014
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Leafline Labs, LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2014$15 MNo. 1$10 to $50 million

Leafline Labs, LLC: Raise no. 1, Dec 2014

Investors in this round

141 investors had bought by the notice of Oct 30, 2015: 141 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $15 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$154,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Limited Liability Company, incorporated in Minnesota

People named in the notice

  • Emmanuel Munson-Regala · Executive Officer
  • Peter Bachman · Executive Officer, Director, Promoter
  • Andrew Bachman · Director, Promoter
  • Ethan Ruby · Director, Promoter
  • Glenn Taylor · Director, Promoter
  • Mitchell Baruchowitz · Director, Promoter
  • Paul Bachman · Director, Promoter
  • Gary Starr · Promoter
  • Kelly Henry · Promoter
  • Mark Bachman · Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Manny Munson-Regala, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Oct 30, 2015. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Leafline Labs, LLC chose not to state its revenue in its newest notice of a funding round (Oct 2015).

    SEC Form D · Oct 2015

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Oct 2015

That is all the official record says: Leafline Labs, LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Leafline Labs, LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 141 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Leafline Labs, LLC
NameRoleNamed in
Emmanuel Munson-RegalaExecutive officerOct 2015
Peter BachmanExecutive officerOct 2015
Christopher WeidlingExecutive officerDec 2014
Andrew BachmanDirectorOct 2015
Ethan RubyDirectorOct 2015
Glenn TaylorDirectorOct 2015
Mitchell BaruchowitzDirectorOct 2015
Paul BachmanDirectorOct 2015
Peter BachmanDirectorOct 2015
Andrew BachmanPromoterOct 2015
Ethan RubyPromoterOct 2015
Gary StarrPromoterOct 2015
Glenn TaylorPromoterOct 2015
Kelly HenryPromoterOct 2015
Mark BachmanPromoterOct 2015
Mitchell BaruchowitzPromoterOct 2015
Paul BachmanPromoterOct 2015
Peter BachmanPromoterOct 2015
Christopher WeidlingPromoterDec 2014